Pharma Business review is using cookies

ContinueLearn More
September 21, 2018

Mylan, Fujifilm Kyowa get EC nod for Humira biosimilar Hulio

Mylan and Fujifilm Kyowa Kirin Biologics have secured marketing authorization from the European Commission (EC) for their Hulio, a biosimilar to AbbVie's Humira (adalimumab), for all indications.

Image: Head office of the European Commission. Photo: courtesy of Amio Cajander.